Stock Analysis | DuPont de Nemours Outlook - A Bearish Technical Profile Amid Mixed Analyst Optimism

Market Snapshot

Takeaway: Despite a 4.21% price rise in recent sessions, technical indicators remain bearish, suggesting a weak trend and caution for potential investors.

News Highlights

• Safex Chemicals Expands Manufacturing: A new $80 MT/day production facility in India aims to boost supply chain resilience and R&D innovation in crop protection. This could indirectly benefit DuPont's agrochemicals segment, though no direct impact is evident yet.
• U.S. Restricts Chip Design Shipments to China: The U.S. is tightening export controls on semiconductor design software and chemicals, which could affect DuPont's materials and electronics segments. The company has exposure to chemical inputs in high-tech manufacturing and may face tighter global supply chain dynamics.
• Genentech’s Itovebi Shows Strong Survival Rates in Breast Cancer: While not directly related to DuPont, this kind of medical innovation could reflect broader R&D trends in life sciences, a sector where DuPont has a presence.

Analyst Views & Fundamentals

Analysts remain generally bullish in the short term, with a simple average rating of 4.33 and a performance-weighted score of 3.85. However, ratings are not consistent, with one "Strong Buy" and two "Buy" ratings in the last 20 days, indicating some divergence in expectations.

Price trend vs. analyst ratings: The stock has seen a 4.21% rise recently, which aligns with a "Buy" bias in the analyst ratings. However, the technical profile remains weak, which could signal a potential short-term correction.

Key fundamental values and model scores:

• Revenue-MV: 0.0195 (Q_rank 2) – Internal diagnostic score: 2/10
• PE Ratio: 856.36 – Internal diagnostic score: 1/10
• Quick Ratio: 0.9386 (93.86%) – Internal diagnostic score: 1/10
• Current Ratio: 1.4115 (141.15%) – Internal diagnostic score: 3/10
• Net Cash Flow from Operating Activities (YoY growth): -25.1961% – Internal diagnostic score: 4/10
• Cash-Up: 0.1648 – Internal diagnostic score: 2/10

Money-Flow Trends

Big-money flows are currently negative, with extra-large inflow ratio at 0.4195 and block inflow ratio at 0.4471, suggesting institutional caution. Retail flows (small investors) are also negative with an inflow ratio of 0.4958, showing no clear support from individual investors.

The overall fund-flow score stands at 7.8/10, labeled "good," which seems contradictory. However, this likely reflects a short-term divergence rather than a structural shift—funds may be rotating rather than exiting the stock entirely.

Key Technical Signals

Technical indicators show a clearly bearish bias, with four negative signals and no bullish ones in the last 5 days.

• WR Oversold: Internal diagnostic score of 3.43/10, indicating limited upside.
• Bearish Engulfing: Strong bearish pattern with an internal score of 1/10.
• MACD Golden Cross: A bullish signal, but scored 6.2/10, suggesting it's not strong enough to counterbalance the bearish trends.
• Earnings Release Date: Historically bearish with a score of 1/10, aligning with recent bearish signals.
• RSI Oversold: Scored 3.42/10, suggesting the stock is near oversold but not enough to trigger a reversal.

Recent indicators by date:

• August 11: WR Oversold
• August 1: WR Oversold and RSI Oversold
• August 15: Bearish Engulfing
• August 5: Earnings Release Date
• August 18: MACD Golden Cross

Key insight: The stock is in a volatile state with no clear direction. Bearish signals dominate with no support from bullish momentum indicators.

Conclusion

Investors should avoid overextending long positions in DD at this time. The technical side remains weak, and while there are some mixed fundamentals and a mild positive sentiment from analysts, the bearish signals (especially the RSI oversold and Bearish Engulfing) suggest caution.

Actionable takeaway: Consider waiting for a pull-back or clearer bullish confirmation, particularly from volume and momentum indicators. Also, monitor the next earnings release for a potential catalyst—though the historical pattern for earnings is bearish.